Standout Papers

Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy 2022 2026 2023 2024175
  1. Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy (2022)
    Yu Fujiwara, Shumei Kato et al. Cancer Treatment Reviews

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 58 standout
Sub-graph 1 of 23

Citing Papers

The interaction of innate immune and adaptive immune system
2024 Standout
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
2024 Standout
3 intermediate papers

Works of Mary Nesline being referenced

Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
2022 Standout
Body Mass Index Influences the Salutary Effects of Metformin on Survival After Lobectomy for Stage I NSCLC
2019
and 2 more

Author Peers

Author Last Decade Papers Cites
Mary Nesline 474 253 187 397 68 1.0k
Jessica Bauer 588 228 113 676 37 1.3k
Mahdi Abdoli Shadbad 545 332 161 534 60 1.3k
Lara Nonell 288 229 81 448 48 1.1k
Jen‐Yu Hung 432 562 354 775 43 1.3k
Man‐Hsin Hung 479 226 268 529 45 1.3k
Timo Muhonen 452 98 148 282 54 1.1k
Mark D. Long 399 350 238 738 66 1.3k
Lucas Leite Cunha 382 88 186 262 44 1.1k
Chen Jiang 400 114 144 324 43 930
Yi Zhao 288 180 147 302 68 1.0k

All Works

Loading papers...

Rankless by CCL
2026